174 related articles for article (PubMed ID: 37835437)
1. Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma.
Nastasi N; Pasha A; Bruno G; Subbiani A; Pietrovito L; Leo A; Scala L; de Simone L; Casazza G; Lunardi F; Taddei ML; Tamburini A; Tondo A; Favre C; Calvani M
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835437
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review.
Jimmy R; Stern C; Lisy K; White S
JBI Database System Rev Implement Rep; 2017 Aug; 15(8):2113-2152. PubMed ID: 28800058
[TBL] [Abstract][Full Text] [Related]
3. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
Kokkali S; Kotsantis I; Magou E; Sophia T; Kormas T; Diakoumis G; Spathas N; Psyrri A; Ardavanis A
Invest New Drugs; 2022 Jun; 40(3):668-675. PubMed ID: 35312944
[TBL] [Abstract][Full Text] [Related]
4. Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.
Anderson PM; Meyers P; Kleinerman E; Venkatakrishnan K; Hughes DP; Herzog C; Huh W; Sutphin R; Vyas YM; Shen V; Warwick A; Yeager N; Oliva C; Wang B; Liu Y; Chou A
Pediatr Blood Cancer; 2014 Feb; 61(2):238-44. PubMed ID: 23997016
[TBL] [Abstract][Full Text] [Related]
5. Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis.
Song HJ; Lee JA; Han E; Lee EK
Tumour Biol; 2015 Sep; 36(9):6773-9. PubMed ID: 25835978
[TBL] [Abstract][Full Text] [Related]
6. Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma.
Brard C; Piperno-Neumann S; Delaye J; Brugières L; Hampson LV; Le Teuff G; Le Deley MC; Gaspar N
BMJ Open; 2019 May; 9(5):e025877. PubMed ID: 31110092
[TBL] [Abstract][Full Text] [Related]
7. Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells.
Punzo F; Bellini G; Tortora C; Pinto DD; Argenziano M; Pota E; Paola AD; Martino MD; Rossi F
Oncotarget; 2020 Feb; 11(7):687-698. PubMed ID: 32133045
[TBL] [Abstract][Full Text] [Related]
8. Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience.
Taçyıldız N; Unal E; Dinçaslan H; Çakmak HM; Köse K; Tanyıldız G; Kartal Ö
Asian Pac J Cancer Prev; 2020 Mar; 21(3):715-720. PubMed ID: 32212798
[TBL] [Abstract][Full Text] [Related]
9. Mifamurtide: a review of its use in the treatment of osteosarcoma.
Frampton JE
Paediatr Drugs; 2010 Jun; 12(3):141-53. PubMed ID: 20481644
[TBL] [Abstract][Full Text] [Related]
10. The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma.
Bellini G; Di Pinto D; Tortora C; Manzo I; Punzo F; Casale F; Rossi F
Curr Cancer Drug Targets; 2017; 17(7):650-656. PubMed ID: 27993113
[TBL] [Abstract][Full Text] [Related]
11. Orphan drugs revisited: cost-effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma.
Brosa M; García del Muro X; Mora J; Villacampa A; Pozo-Rubio T; Cubells L; Montoto C
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):331-40. PubMed ID: 25354299
[TBL] [Abstract][Full Text] [Related]
12. L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.
Biteau K; Guiho R; Chatelais M; Taurelle J; Chesneau J; Corradini N; Heymann D; Redini F
Am J Cancer Res; 2016; 6(3):677-89. PubMed ID: 27152244
[TBL] [Abstract][Full Text] [Related]
13. The addition of mifamurtide to chemotherapy improves lifetime effectiveness in children with osteosarcoma: a Markov model analysis.
Song HJ; Lee EK; Lee JA; Kim HL; Jang KW
Tumour Biol; 2014 Sep; 35(9):8771-9. PubMed ID: 24874050
[TBL] [Abstract][Full Text] [Related]
14. Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis.
Johal S; Ralston S; Knight C
Value Health; 2013 Dec; 16(8):1123-32. PubMed ID: 24326165
[TBL] [Abstract][Full Text] [Related]
15. Mifamurtide: osteosarcoma: ineffective and harmful.
Prescrire Int; 2011 Apr; 20(115):89. PubMed ID: 21648206
[TBL] [Abstract][Full Text] [Related]
16. What has changed in the last 25 years in osteosarcoma treatment? A single center experience.
Ataseven E; Göktepe ŞÖ; Kaya H; Tamsel İ; Keçeci B; Argın M; Doğanavşargil B; Sabah D; Burak Z; Kantar M
Turk J Pediatr; 2023; 65(1):54-63. PubMed ID: 36866985
[TBL] [Abstract][Full Text] [Related]
17. Mifamurtide: CGP 19835, CGP 19835A, L-MTP-PE, liposomal MTP-PE, MLV 19835A, MTP-PE, muramyltripeptide phosphatidylethanolamine.
Drugs R D; 2008; 9(2):131-5. PubMed ID: 18298131
[TBL] [Abstract][Full Text] [Related]
18. Mifamurtide in osteosarcoma--a practical review.
Anderson PM; Tomaras M; McConnell K
Drugs Today (Barc); 2010 May; 46(5):327-37. PubMed ID: 20517534
[TBL] [Abstract][Full Text] [Related]
19. Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Múdry P; Kýr M; Rohleder O; Mahdal M; Staniczková Zambo I; Ježová M; Tomáš T; Štěrba J
J Bone Oncol; 2021 Jun; 28():100362. PubMed ID: 33948428
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Palmerini E; Meazza C; Tamburini A; Bisogno G; Ferraresi V; Asaftei SD; Milano GM; Coccoli L; Manzitti C; Luksch R; Serra M; Gambarotti M; Donati DM; Scotlandi K; Bertulli R; Favre C; Longhi A; Abate ME; Perrotta S; Mascarin M; D'Angelo P; Cesari M; Staals EL; Marchesi E; Carretta E; Ibrahim T; Casali PG; Picci P; Fagioli F; Ferrari S
Cancer; 2022 May; 128(10):1958-1966. PubMed ID: 35201621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
